import { PrismaClient } from "@prisma/client";
import { PrismaPg } from "@prisma/adapter-pg";
import "dotenv/config";

const adapter = new PrismaPg({ connectionString: process.env.DATABASE_URL! });
const prisma = new PrismaClient({ adapter });

const posts = [
  {
    title: "The Renaissance of Peptide Research: What's Driving the Boom",
    slug: "renaissance-of-peptide-research",
    excerpt: "Peptide research is experiencing an unprecedented surge. From longevity science to metabolic health, we explore the forces reshaping this fascinating field.",
    category: "Industry News",
    author: "ReVia Research Team",
    image: "https://images.unsplash.com/photo-1532187863486-abf9dbad1b69?w=800&h=400&fit=crop",
    content: `<p>Something remarkable is happening in the world of peptide science. Over the past five years, research publications on synthetic peptides have grown by over 40%, and institutional funding for peptide-based studies has reached historic levels. What's driving this renaissance?</p>

<h2>The Perfect Storm of Innovation</h2>
<p>Several converging forces have placed peptides at the center of modern biomedical research. Advances in solid-phase peptide synthesis have dramatically reduced production costs, making compounds that were once prohibitively expensive accessible to a broader range of research institutions. At the same time, our understanding of cellular signaling pathways has deepened enormously, revealing peptides as key mediators in nearly every biological process.</p>

<p>The GLP-1 agonist revolution — driven by compounds like semaglutide and tirzepatide — has thrust peptide science into the mainstream consciousness. While media coverage has focused on weight management applications, researchers are investigating these molecules across a stunning range of biological contexts, from neuroprotection to cardiovascular function.</p>

<h2>Beyond the Headlines</h2>
<p>What the popular press misses is the breadth of the peptide research landscape. While metabolic peptides capture headlines, equally exciting work is happening in regenerative medicine (BPC-157, TB-500), cognitive science (Semax, Selank), longevity (Epithalon, SS-31), and immunology (Thymosin Alpha-1).</p>

<blockquote>The diversity of peptide research reflects a fundamental truth: these molecules are the language cells use to communicate, and we're only beginning to become fluent.</blockquote>

<p>Mitochondrial-targeted peptides like SS-31 and MOTS-c represent a particularly exciting frontier. Published research suggests these compounds can influence cellular energy production at its source, with implications for understanding aging, metabolic health, and exercise physiology.</p>

<h2>The Democratization of Research</h2>
<p>Perhaps the most significant trend is the democratization of peptide research. Independent researchers, small labs, and academic institutions now have access to high-purity compounds that were once available only to large pharmaceutical companies. This broader access is accelerating discovery and bringing fresh perspectives to longstanding scientific questions.</p>

<p>Quality suppliers play a crucial role in this ecosystem. Researchers depend on consistent purity, proper handling, and transparent documentation. As the field grows, the relationship between supplier and researcher becomes a partnership in advancing science.</p>

<h2>Looking Ahead</h2>
<p>The next decade of peptide research promises to be even more dynamic. Emerging areas include peptide-drug conjugates, cell-penetrating peptides for targeted delivery, and AI-designed peptide sequences. The tools are getting sharper, the questions more precise, and the potential more exciting than ever.</p>

<p>At ReVia, we're proud to support this community with research-grade compounds, and we can't wait to see what discoveries lie ahead.</p>

<p><em>All products mentioned are for research use only. Not for human consumption.</em></p>`,
  },
  {
    title: "Understanding BPC-157: Why Researchers Can't Stop Studying This Peptide",
    slug: "understanding-bpc-157-research",
    excerpt: "BPC-157 is one of the most studied peptides in regenerative research. Here's what the published literature actually shows — and why scientists find it so compelling.",
    category: "Research Spotlight",
    author: "ReVia Research Team",
    image: "https://images.unsplash.com/photo-1559757175-5700dde675bc?w=800&h=400&fit=crop",
    content: `<p>If you follow peptide research at all, you've encountered BPC-157. This 15-amino-acid peptide, derived from a protein found in gastric juice, has generated an extraordinary volume of published research — and for good reason.</p>

<h2>What Makes BPC-157 Unique</h2>
<p>BPC stands for "Body Protection Compound," a name that hints at the breadth of its studied effects. Unlike many peptides that target a single receptor or pathway, BPC-157 appears to interact with multiple biological systems simultaneously. Published studies have examined its effects on angiogenesis, nitric oxide pathways, the GABAergic system, and growth factor expression.</p>

<p>This multi-pathway activity is what makes BPC-157 so fascinating to researchers. In a field where most compounds are studied for a single mechanism, a peptide that touches multiple systems presents both challenges and opportunities for understanding biological complexity.</p>

<h2>The Published Research</h2>
<p>The literature on BPC-157 is substantial. Hundreds of peer-reviewed studies, primarily conducted in rodent models, have examined its effects across numerous research contexts:</p>

<ul>
<li><strong>Gastrointestinal research:</strong> Studies have investigated BPC-157's effects on gastric lesions, inflammatory bowel models, and intestinal anastomosis healing</li>
<li><strong>Musculoskeletal research:</strong> Published work has explored tendon, ligament, and muscle tissue repair models</li>
<li><strong>Neurological research:</strong> Studies have examined neuroprotective properties and effects on dopaminergic systems</li>
<li><strong>Vascular research:</strong> BPC-157's effects on blood vessel formation and vascular function have been documented</li>
</ul>

<h2>The Stacking Phenomenon</h2>
<p>Researchers frequently study BPC-157 in combination with other peptides, particularly TB-500 (Thymosin Beta-4 fragment). The rationale is that BPC-157's local tissue effects may complement TB-500's systemic activity, though more research is needed to fully characterize these interactions.</p>

<p>Our Phoenix and Ironclad stacks were designed with this research in mind — combining BPC-157 with complementary compounds that researchers frequently study together.</p>

<h2>What We Still Don't Know</h2>
<p>Despite the volume of published research, important questions remain. Most studies have been conducted in animal models, and the mechanisms underlying BPC-157's broad activity profile aren't fully characterized. This is precisely why continued research is so important — and why quality research materials matter.</p>

<p><em>All products mentioned are for research use only. Not for human consumption.</em></p>`,
  },
  {
    title: "GLP-1 Agonists Beyond the Headlines: What Semaglutide Research Really Shows",
    slug: "glp1-agonists-beyond-headlines",
    excerpt: "The media frenzy around GLP-1 agonists has overshadowed the nuanced science. Let's look at what researchers are actually finding — and what questions remain.",
    category: "Research Spotlight",
    author: "ReVia Research Team",
    image: "https://images.unsplash.com/photo-1576671081837-49000212a370?w=800&h=400&fit=crop",
    content: `<p>It's impossible to discuss modern peptide research without addressing the elephant in the room: GLP-1 receptor agonists. Semaglutide, tirzepatide, and retatrutide have become household names, but the popular narrative barely scratches the surface of what researchers are discovering.</p>

<h2>The Science Behind the Headlines</h2>
<p>GLP-1 (glucagon-like peptide-1) is a naturally occurring incretin hormone that plays key roles in glucose homeostasis and appetite regulation. Synthetic GLP-1 agonists were originally developed and studied in the context of metabolic research, but their biological activity extends far beyond what early researchers anticipated.</p>

<p>Published studies have now examined GLP-1 agonists in the context of cardiovascular function, neuroprotection, liver health, and inflammatory processes. This breadth of research reflects the widespread distribution of GLP-1 receptors throughout the body — they're not just in the pancreas.</p>

<h2>The Next Generation: Dual and Triple Agonists</h2>
<p>While semaglutide targets GLP-1 receptors alone, newer compounds broaden the approach:</p>

<ul>
<li><strong>Tirzepatide:</strong> A dual GIP/GLP-1 receptor agonist that has shown remarkable results in metabolic research</li>
<li><strong>Retatrutide:</strong> A triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously</li>
<li><strong>Survodutide:</strong> A dual GLP-1/glucagon agonist being studied for its unique metabolic profile</li>
<li><strong>Cagrilintide + Semaglutide:</strong> Combining amylin and GLP-1 pathways</li>
</ul>

<p>Each of these compounds opens new research questions about receptor cross-talk, synergistic signaling, and the complex biology of metabolic regulation.</p>

<h2>What the Media Gets Wrong</h2>
<p>The popular press tends to frame GLP-1 research as a simple weight loss story. Researchers know better. These compounds are windows into fundamental questions about energy homeostasis, appetite neurocircuitry, and metabolic disease pathogenesis. The weight management applications, while clinically significant, are really just one manifestation of deeper biological principles.</p>

<h2>The Research Continues</h2>
<p>We're still in the early chapters of GLP-1 agonist research. Questions about long-term effects, optimal dosing paradigms, and the full scope of receptor-mediated activity remain active areas of investigation. For researchers in this space, it's an extraordinarily exciting time.</p>

<p><em>All products mentioned are for research use only. Not for human consumption.</em></p>`,
  },
  {
    title: "Mitochondrial Peptides: The Next Frontier in Longevity Research",
    slug: "mitochondrial-peptides-longevity-frontier",
    excerpt: "SS-31, MOTS-c, and NAD+ precursors are reshaping how we think about aging. Here's why researchers are so excited about mitochondrial-targeted compounds.",
    category: "Research Spotlight",
    author: "ReVia Research Team",
    image: "https://images.unsplash.com/photo-1628595351029-c2bf17511435?w=800&h=400&fit=crop",
    content: `<p>If you want to understand aging, look at the mitochondria. These ancient organelles — once free-living bacteria that took up residence in our cells over a billion years ago — are increasingly recognized as central players in the aging process. And a new class of peptides is giving researchers unprecedented tools to study them.</p>

<h2>The Mitochondrial Theory of Aging</h2>
<p>The idea that mitochondrial dysfunction drives aging isn't new, but recent research has added remarkable nuance. We now understand that mitochondria don't just produce energy — they regulate cell death, inflammatory signaling, calcium homeostasis, and even gene expression. When they falter, the effects cascade throughout the entire organism.</p>

<h2>SS-31 (Elamipretide): Targeting the Inner Membrane</h2>
<p>SS-31 is a tetrapeptide that concentrates in the inner mitochondrial membrane, where the electron transport chain resides. Published research has demonstrated its ability to stabilize cardiolipin — a phospholipid critical for optimal electron transport — and reduce the production of reactive oxygen species at their source.</p>

<p>What makes SS-31 remarkable is its specificity. Rather than acting as a general antioxidant (which can actually interfere with beneficial ROS signaling), SS-31 targets the specific site where pathological ROS generation occurs. This precision has made it a favorite among researchers studying mitochondrial dysfunction.</p>

<h2>MOTS-c: The Mitochondrial-Derived Peptide</h2>
<p>MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome itself — one of the first mitochondrial-derived peptides (MDPs) discovered. Published research has shown that MOTS-c activates AMPK, a master metabolic sensor, and influences glucose metabolism, exercise capacity, and stress resistance in research models.</p>

<p>The discovery of MOTS-c reshaped our understanding of mitochondria. These organelles aren't just energy factories — they're endocrine organs that communicate with the rest of the cell through peptide signaling.</p>

<h2>NAD+ and the Sirtuin Connection</h2>
<p>While not a peptide per se, NAD+ is intimately connected to mitochondrial function and frequently studied alongside mitochondrial peptides. NAD+ fuels sirtuins — a family of enzymes that regulate DNA repair, gene expression, and mitochondrial biogenesis. Age-related NAD+ decline is one of the most consistent findings in aging research.</p>

<p>Our Supernova stack combines MOTS-c, SS-31, and NAD+ precisely because researchers studying mitochondrial function often investigate these compounds together — each targeting a different aspect of the same fundamental biology.</p>

<h2>The Road Ahead</h2>
<p>Mitochondrial peptide research is still young, but it's growing rapidly. New MDPs are being discovered, delivery methods are improving, and our understanding of mitochondrial communication networks deepens with each published study. For longevity researchers, this is arguably the most exciting frontier in the field.</p>

<p><em>All products mentioned are for research use only. Not for human consumption.</em></p>`,
  },
  {
    title: "The Science of Stacking: How Researchers Combine Peptides for Synergistic Effects",
    slug: "science-of-peptide-stacking",
    excerpt: "Why do researchers combine multiple peptides? The answer lies in biological synergy — and the results can be greater than the sum of their parts.",
    category: "Education",
    author: "ReVia Research Team",
    image: "https://images.unsplash.com/photo-1532187863486-abf9dbad1b69?w=800&h=400&fit=crop",
    content: `<p>In pharmaceutical research, combination therapy is a well-established principle: sometimes two compounds working together achieve effects that neither can accomplish alone. The same logic drives peptide stacking in research settings — and the science behind it is more rigorous than you might expect.</p>

<h2>Why Stack? The Logic of Synergy</h2>
<p>Biological systems are complex networks, not linear pathways. A single peptide targeting a single receptor can produce meaningful effects, but combining peptides that target complementary pathways can create synergistic outcomes. This isn't just additive — true synergy means the combined effect exceeds what you'd predict from each compound individually.</p>

<h2>Classic Research Combinations</h2>
<p>Several peptide combinations have become standards in the research community, supported by published literature and established research protocols:</p>

<ul>
<li><strong>BPC-157 + TB-500:</strong> Perhaps the most studied combination. BPC-157's local tissue effects (angiogenesis, growth factor modulation) complement TB-500's systemic activity (actin regulation, cell migration). Our Phoenix and Ironclad stacks are built on this foundation.</li>
<li><strong>CJC-1295 + Ipamorelin:</strong> Researchers studying growth hormone secretion frequently combine a GHRH analog with a ghrelin mimetic. The two pathways converge on GH release through different mechanisms, potentially producing a more physiological secretion pattern.</li>
<li><strong>Semax + Selank:</strong> Our Clarity stack combines these nootropic peptides because they target complementary neurotransmitter systems — Semax influences BDNF and catecholamines, while Selank modulates GABA and serotonin.</li>
</ul>

<h2>The ReVia Stack Philosophy</h2>
<p>Every ReVia stack is designed around published research and established synergy principles. We don't combine compounds randomly — each stack targets a specific research area with peptides that work through complementary mechanisms.</p>

<p>Take our Timeless stack (Epithalon + NAD+ + GHK-Cu): it addresses aging research from three angles — telomere maintenance, cellular energy metabolism, and tissue remodeling. Each component has standalone research value, but together they give researchers a multi-target approach to studying aging processes.</p>

<h2>Building Your Own</h2>
<p>We also support researchers who want to build custom combinations. Our Build Your Own Stack option offers a 10% discount when selecting 3 or more products, because we believe the best research comes from giving scientists the flexibility to follow their hypotheses wherever they lead.</p>

<p><em>All products mentioned are for research use only. Not for human consumption.</em></p>`,
  },
  {
    title: "GHK-Cu: The Copper Peptide That Does (Almost) Everything",
    slug: "ghk-cu-copper-peptide-research",
    excerpt: "From skin biology to gene expression, GHK-Cu research spans an astonishing range. We explore why this humble tripeptide has captivated researchers across disciplines.",
    category: "Research Spotlight",
    author: "ReVia Research Team",
    image: "https://images.unsplash.com/photo-1596755389378-c31d21fd1273?w=800&h=400&fit=crop",
    content: `<p>GHK-Cu might be the most underappreciated peptide in research. This simple tripeptide — just three amino acids complexed with copper — has generated a body of published literature that spans dermatology, wound healing, gene expression, and even oncology research. For a molecule this small, its studied effects are remarkably broad.</p>

<h2>The Basics</h2>
<p>GHK (glycyl-L-histidyl-L-lysine) was first isolated from human plasma in 1973 by Dr. Loren Pickart. It naturally occurs in blood, saliva, and urine, with plasma concentrations declining significantly with age. When complexed with copper (GHK-Cu), it forms a stable compound with enhanced biological activity.</p>

<h2>What the Research Shows</h2>
<p>The published research on GHK-Cu is remarkably diverse:</p>

<ul>
<li><strong>Collagen and skin biology:</strong> Numerous studies have demonstrated GHK-Cu's effects on collagen synthesis, elastin production, and glycosaminoglycan formation in cell culture models</li>
<li><strong>Wound healing:</strong> Research has shown effects on angiogenesis, nerve outgrowth, and the recruitment of immune cells to wound sites</li>
<li><strong>Gene expression:</strong> Perhaps most impressively, a 2014 study identified over 4,000 genes whose expression was modulated by GHK-Cu — many of which are associated with tissue remodeling and repair</li>
<li><strong>Hair follicle biology:</strong> Studies have examined GHK-Cu's effects on follicle size and hair growth cycle regulation</li>
<li><strong>Antioxidant activity:</strong> Research shows GHK-Cu can modulate expression of antioxidant enzymes including superoxide dismutase</li>
</ul>

<h2>Why Researchers Love It</h2>
<p>GHK-Cu occupies a unique niche in peptide research. It's naturally occurring, well-characterized, stable, and affects multiple pathways simultaneously. For researchers studying tissue remodeling, aging, or wound biology, it's an invaluable tool compound.</p>

<p>Its presence in several of our stacks — Lumina, Renaissance, Ironclad, and Timeless — reflects how frequently researchers combine GHK-Cu with other compounds to study complex biological processes.</p>

<h2>The Copper Factor</h2>
<p>Copper itself is an essential trace element involved in numerous enzymatic reactions. The copper in GHK-Cu serves both as a structural component and as a biologically active element. Research suggests that GHK-Cu may serve as a copper delivery system, facilitating copper-dependent enzymatic processes at specific tissue sites.</p>

<p><em>All products mentioned are for research use only. Not for human consumption.</em></p>`,
  },
  {
    title: "Nootropic Peptides: What the Research Says About Cognitive Enhancement",
    slug: "nootropic-peptides-cognitive-research",
    excerpt: "Semax, Selank, Dihexa, and Cerebrolysin represent a fascinating class of peptides studied for their effects on the brain. Here's what the published literature reveals.",
    category: "Research Spotlight",
    author: "ReVia Research Team",
    image: "https://images.unsplash.com/photo-1559757148-5c350d0d3c56?w=800&h=400&fit=crop",
    content: `<p>The brain is the most complex organ in the known universe, and peptides that influence cognitive function represent some of the most intellectually fascinating areas of modern research. Nootropic peptides — compounds studied for their effects on memory, learning, neuroprotection, and cognitive performance — are drawing increasing attention from neuroscience researchers worldwide.</p>

<h2>Semax: Russia's Neuroscience Contribution</h2>
<p>Semax, a synthetic analog of ACTH(4-7), was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Published research has shown effects on BDNF (brain-derived neurotrophic factor) expression — a protein critical for neuronal survival, growth, and synaptic plasticity.</p>

<p>Studies have also examined Semax's effects on dopaminergic and serotonergic systems, making it a valuable research tool for studying the intersection of neurotrophic signaling and monoamine neurotransmission.</p>

<h2>Selank: The Anxiolytic Peptide</h2>
<p>Selank, a synthetic analog of the immunomodulatory peptide tuftsin, has been studied extensively for its effects on GABAergic neurotransmission and anxiety-related behaviors in animal models. Published research suggests it modulates the balance between excitatory and inhibitory neurotransmission without the sedation associated with traditional GABAergic compounds.</p>

<p>Our Clarity stack pairs Semax and Selank based on the research rationale that cognitive enhancement and anxiety reduction often work synergistically — a stressed brain doesn't learn well.</p>

<h2>Dihexa: The Potent Newcomer</h2>
<p>Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) has generated significant research interest since its 2013 publication in the Journal of Pharmacology and Experimental Therapeutics. Studies showed it was approximately 10 million times more potent than BDNF in promoting synaptic connectivity, working through the hepatocyte growth factor (HGF) receptor system.</p>

<h2>Cerebrolysin: The Neuropeptide Mix</h2>
<p>Cerebrolysin is a mixture of low-molecular-weight neuropeptides derived from porcine brain tissue. It has been studied in over 200 published clinical trials and preclinical studies, primarily in the context of neurodegenerative research and cognitive function. Its complex composition — multiple peptides working together — makes it a unique research tool for studying neuroprotection.</p>

<h2>The Future of Cognitive Peptide Research</h2>
<p>As our understanding of brain plasticity deepens, nootropic peptides will likely play an increasingly important role in neuroscience research. These compounds give researchers precise tools to probe specific aspects of cognitive function, neuroplasticity, and neuroprotection.</p>

<p><em>All products mentioned are for research use only. Not for human consumption.</em></p>`,
  },
  {
    title: "Quality Matters: How to Evaluate a Peptide Supplier",
    slug: "how-to-evaluate-peptide-supplier",
    excerpt: "Not all peptide suppliers are created equal. Here's what savvy researchers look for when choosing where to source their research compounds.",
    category: "Education",
    author: "ReVia Research Team",
    image: "https://images.unsplash.com/photo-1583912086096-8c60d75a53f9?w=800&h=400&fit=crop",
    content: `<p>In peptide research, your results are only as good as your materials. A compound with unknown purity, degraded potency, or incorrect composition can waste months of work and lead to irreproducible findings. Choosing the right supplier isn't just about price — it's about protecting the integrity of your research.</p>

<h2>The Five Pillars of Supplier Quality</h2>

<h2>1. Purity Verification</h2>
<p>Look for suppliers who provide third-party testing documentation. HPLC (High-Performance Liquid Chromatography) analysis should show purity levels of 98% or higher for most research peptides. Mass spectrometry (MS) confirmation of molecular identity is equally important — it ensures you're actually getting the correct peptide, not a similar but different compound.</p>

<h2>2. Certificate of Analysis (COA)</h2>
<p>A legitimate supplier provides COAs for every batch. These should include HPLC purity data, MS molecular weight confirmation, appearance description, and testing date. Be wary of suppliers who can't or won't provide batch-specific COAs on request.</p>

<h2>3. Proper Storage and Handling</h2>
<p>Peptides are sensitive molecules. They can degrade with heat, moisture, and light exposure. Quality suppliers store lyophilized peptides under appropriate conditions (typically 2-8°C or frozen) and ship with cold packs when necessary. Ask about a supplier's storage and shipping protocols.</p>

<h2>4. Transparent Sourcing</h2>
<p>Where are the peptides synthesized? What quality management systems are in place? Reputable suppliers are transparent about their supply chain and manufacturing standards. Look for GMP or GMP-adjacent manufacturing when possible.</p>

<h2>5. Customer Support and Expertise</h2>
<p>A quality supplier employs people who understand the science. Can they answer technical questions about their products? Do they provide handling and storage guidance? The best supplier relationships feel like partnerships, not transactions.</p>

<h2>Red Flags to Watch For</h2>
<ul>
<li>No COAs available or only generic (non-batch-specific) documentation</li>
<li>Prices dramatically below market rates (if it seems too good to be true...)</li>
<li>Making therapeutic or medical claims about research compounds</li>
<li>No clear contact information or customer service</li>
<li>Packaging that doesn't include proper labeling and lot numbers</li>
</ul>

<h2>The ReVia Standard</h2>
<p>At ReVia, we hold ourselves to the highest standards of quality. Every compound we offer is third-party tested, batch-documented, and handled with the care that serious research demands. We believe that quality isn't a marketing claim — it's the foundation of good science.</p>

<p><em>All products mentioned are for research use only. Not for human consumption.</em></p>`,
  },
  {
    title: "The Gut-Brain Axis: How Peptide Research Is Connecting Digestion and Cognition",
    slug: "gut-brain-axis-peptide-research",
    excerpt: "The connection between gut health and brain function is one of the most exciting areas of modern biology. Peptide research is at the forefront of understanding this remarkable link.",
    category: "Research Spotlight",
    author: "ReVia Research Team",
    image: "https://images.unsplash.com/photo-1505751172876-fa1923c5c528?w=800&h=400&fit=crop",
    content: `<p>Hippocrates said "all disease begins in the gut" over 2,000 years ago. Modern research is proving him remarkably prescient. The gut-brain axis — the bidirectional communication network between the gastrointestinal tract and the central nervous system — has emerged as one of the most dynamic areas of biomedical research, and peptides are providing key tools for studying it.</p>

<h2>The Vagus Highway</h2>
<p>The vagus nerve serves as the primary communication cable between gut and brain, carrying information in both directions. But the signaling isn't limited to neural pathways — peptide hormones, immune mediators, and even microbial metabolites participate in this cross-talk. Many of these signaling molecules are, themselves, peptides.</p>

<h2>BPC-157 and the Gut-Brain Connection</h2>
<p>BPC-157 is perhaps the most studied peptide in gut-brain axis research. Originally isolated from gastric juice, this compound has been investigated for effects on both gastrointestinal and neurological systems. Published research has examined its interactions with the dopaminergic system, nitric oxide pathways, and the GABAergic system — all of which have both gut and brain components.</p>

<p>Our Second Sunrise stack, combining BPC-157 and KPV, was designed with gut-brain axis research in mind. KPV's anti-inflammatory properties complement BPC-157's regenerative effects, offering researchers a multi-target approach to studying gastrointestinal biology.</p>

<h2>GLP-1 and the Brain</h2>
<p>GLP-1 receptors are found not only in the pancreas and gut, but also extensively in the brain — particularly in areas associated with appetite regulation, reward processing, and neuroprotection. Research on semaglutide and tirzepatide increasingly focuses on their central nervous system effects, adding new dimensions to our understanding of metabolic-neurological cross-talk.</p>

<h2>The Microbiome Factor</h2>
<p>The gut microbiome produces its own array of peptide-like molecules that influence brain function. Researchers studying the microbiome-gut-brain axis are using peptides as tools to probe specific pathways while holding others constant — an approach that's yielding increasingly nuanced insights into this complex system.</p>

<h2>Why This Matters</h2>
<p>Understanding the gut-brain axis could transform our approach to studying conditions that have traditionally been considered purely neurological or purely gastrointestinal. Peptide research is at the leading edge of this paradigm shift, providing precise molecular tools for dissecting one of biology's most intricate communication networks.</p>

<p><em>All products mentioned are for research use only. Not for human consumption.</em></p>`,
  },
  {
    title: "2025 Peptide Research Trends: What to Watch This Year",
    slug: "2025-peptide-research-trends",
    excerpt: "From triple-agonist metabolic peptides to AI-designed sequences, here are the trends shaping peptide research in 2025 and beyond.",
    category: "Trends",
    author: "ReVia Research Team",
    image: "https://images.unsplash.com/photo-1451187580459-43490279c0fa?w=800&h=400&fit=crop",
    content: `<p>The peptide research landscape is evolving faster than ever. As we move through 2025, several trends are reshaping the field — some building on established work, others representing genuinely new directions. Here's what we're watching.</p>

<h2>1. Multi-Agonist Metabolic Peptides</h2>
<p>The evolution from mono-agonists (semaglutide) to dual-agonists (tirzepatide) to triple-agonists (retatrutide) represents a paradigm shift in metabolic research. Researchers are increasingly studying how targeting multiple receptor systems simultaneously affects metabolic outcomes, and early published data on triple-agonist compounds has generated significant excitement.</p>

<p>Expect to see more research on survodutide (GLP-1/glucagon dual agonist), mazdutide (oxyntomodulin analog), and novel combinations like cagrilintide + semaglutide that pair GLP-1 signaling with amylin pathways.</p>

<h2>2. Mitochondrial Medicine Goes Mainstream</h2>
<p>Mitochondrial-targeted therapies are moving from niche academic interest to mainstream research priority. SS-31, MOTS-c, and related compounds are being studied across an expanding range of contexts, from exercise physiology to neurodegenerative research. The recognition that mitochondrial dysfunction underpins many age-related conditions is driving substantial funding into this area.</p>

<h2>3. AI-Designed Peptide Sequences</h2>
<p>Machine learning is revolutionizing peptide design. AI models trained on millions of protein structures can now predict peptide-receptor interactions with remarkable accuracy, enabling researchers to design novel sequences with predicted biological activity. This computational approach is dramatically accelerating the discovery pipeline.</p>

<h2>4. Peptide-Drug Conjugates (PDCs)</h2>
<p>Inspired by antibody-drug conjugates in oncology, researchers are exploring peptides as targeted delivery vehicles. By conjugating therapeutic payloads to peptides that bind specific receptors, researchers can potentially achieve tissue-targeted delivery with reduced off-target effects.</p>

<h2>5. Oral Peptide Delivery</h2>
<p>Historically, peptides required injection due to degradation in the GI tract. New formulation technologies — including permeation enhancers, nanoparticle encapsulation, and protease-resistant analogs — are making oral peptide delivery increasingly viable. Oral semaglutide paved the way, and more oral peptide formulations are in development.</p>

<h2>6. Epigenetic Peptides</h2>
<p>Research on peptides that influence epigenetic modifications — changes in gene expression without altering DNA sequence — is gaining momentum. Epithalon's studied effects on telomerase expression sit at this intersection, and newer compounds are being designed to target specific epigenetic pathways.</p>

<h2>7. Regulatory Evolution</h2>
<p>The regulatory landscape around research peptides continues to evolve. Researchers should stay informed about FDA guidance, state-level regulations, and international frameworks that may affect compound availability and research protocols.</p>

<h2>Looking Forward</h2>
<p>The peptide research field has never been more dynamic. At ReVia, we're committed to staying ahead of these trends and ensuring our catalog reflects the evolving needs of the research community. The best science happens when researchers have access to the right tools at the right time.</p>

<p><em>All products mentioned are for research use only. Not for human consumption.</em></p>`,
  },
];

async function main() {
  console.log("Seeding blog posts...");

  for (const post of posts) {
    await prisma.blogPost.upsert({
      where: { slug: post.slug },
      update: post,
      create: post,
    });
    console.log(`  Created: ${post.title}`);
  }

  const count = await prisma.blogPost.count();
  console.log(`\nBlog seeding complete! ${count} posts.`);
}

main()
  .catch((e) => {
    console.error(e);
    process.exit(1);
  })
  .finally(() => prisma.$disconnect());
